Mustbio
Seoul
About Mustbio
MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $35.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2026)
- Website: mustbio.com
- Phone: 031-893-2910
Industries & Categories
Biotechnology, Health Care, Medical, Oncology
Canonical: https://fsome.com/organization/mustbio-86189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.